Literature DB >> 12735640

Microorganisms in intertriginous psoriasis: no evidence of Candida.

Ingela Flytström1, Ing-Marie Bergbrant, Johanna Bråred, Lena Lind Brandberg.   

Abstract

Infection can be a trigger and an aggravating factor in psoriasis. Antibacterial and/or antifungal agents are commonly used in the treatment of intertriginous psoriasis, because it is believed that flexures in psoriasis are often colonized by Candida species and Staphylococcus aureus. Bacterial and fungal cultures were studied from 32 psoriatic patients with no topical treatment in the intertriginous areas, from 13 psoriatic patients treated with topical steroids and from 19 patients with no psoriasis or other affections of the skinfolds. Untreated psoriatic patients were colonized by S. aureus significantly more often than the control group but infection seemed to be unlikely. Candida was not found in any of the groups. It is proposed that intertriginous psoriasis be treated with topical steroids alone and that the routine use of antimycotic and antibacterial combinations should be avoided.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735640     DOI: 10.1080/00015550310007463

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

Review 1.  [Intertriginous psoriasis].

Authors:  C Thomas; M Matthies; B Homey; S Meller
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

Review 2.  [Psoriasis in special localizations].

Authors:  A Schmieder; W K Peitsch
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 3.  Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Aldona Pietrzak; Ewelina Grywalska; Mateusz Socha; Jacek Roliński; Kinga Franciszkiewicz-Pietrzak; Lidia Rudnicka; Marcin Rudzki; Dorota Krasowska
Journal:  Mediators Inflamm       Date:  2018-05-06       Impact factor: 4.711

4.  Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis.

Authors:  Carmen de Jesús-Gil; Lídia Sans-de San Nicolàs; Ester Ruiz-Romeu; Marta Ferran; Laura Soria-Martínez; Irene García-Jiménez; Anca Chiriac; Josep Manel Casanova-Seuma; Josep Manel Fernández-Armenteros; Sherry Owens; Antonio Celada; Michael D Howell; Ramòn María Pujol; Luis Francisco Santamaria-Babí
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

5.  Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors.

Authors:  Abdulhadi Jfri; Bonnie Leung; Jordan T Said; Yevgeniy Semenov; Nicole R LeBoeuf
Journal:  Immunother Adv       Date:  2022-09-23

Review 6.  Inverse Psoriasis: From Diagnosis to Current Treatment Options.

Authors:  Giuseppe Micali; Anna Elisa Verzì; Giorgia Giuffrida; Enrico Panebianco; Maria Letizia Musumeci; Francesco Lacarrubba
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.